QUOTE AND NEWS
FierceBiotech  Jul 19  Comment 
After a string of pipeline failures, Vical has called in advisers to help decide the future of the company. The move comes just over a month after Vical abandoned work on a genital herpes vaccine following a negative phase 2 trial.
GenEng News  Jun 11  Comment 
Vical acknowledged today that it has halted development of its bivalent vaccine candidate for herpes simplex virus type 2 (HSV-2) after it failed a Phase II trial—the company’s second clinical setback this year involving a lead product. ...
FierceBiotech  Jun 11  Comment 
The deluge of bad news reported by Vical just won’t let up. The biotech confirmed today it has abandoned its lead genital herpes vaccine program after a negative phase 2 trial, following in the footsteps of earlier cancer and cytomegalovirus...
MarketWatch  Jun 11  Comment 
Vical Inc. said Monday a phase 2 trial of its treatment for genital herpes failed to meet its primary endpoint of annualized lesion recurrence rate. The stock was still inactive in premarket trade. In a study of 261 healthy adults with herpes...





You may also be interested in articles related to Vical (VICL):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki